These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19189704)

  • 1. Thyroid stimulating immunoglobulin is often negative in children with Graves' disease.
    Rahhal SN; Eugster EA
    J Pediatr Endocrinol Metab; 2008 Nov; 21(11):1085-8. PubMed ID: 19189704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional TSH receptor antibodies in children with autoimmune thyroid diseases.
    Stożek K; Bossowski A; Ziora K; Bossowska A; Mrugacz M; Noczyńska A; Walczak M; Petriczko E; Pyrżak B; Kucharska A; Szalecki M; Diana T; Kahaly GJ
    Autoimmunity; 2018 Mar; 51(2):62-68. PubMed ID: 29372654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis.
    Silva de Morais N; Angell TE; Ahmadi S; Alexander EK; Dos Santos Teixeira PF; Marqusee E
    Endocr Pract; 2022 May; 28(5):502-508. PubMed ID: 35091101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
    Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
    J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves' disease and predictors of responsiveness to methimazole.
    Liu K; Fu Y; Li T; Liu S; Chen D; Zhao C; Shi Y; Cai Y; Yang T; Zheng X
    Clin Biochem; 2021 Nov; 97():34-40. PubMed ID: 34331946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of a chimeric TSH receptor (Mc4)-based bioassay for Graves' disease.
    Lee JI; Jang HW; Kim SK; Choi JY; Kim JY; Hur KY; Kim JH; Min YK; Chung JH; Kim SW
    Korean J Intern Med; 2011 Jun; 26(2):179-86. PubMed ID: 21716594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.
    Khoo DH; Ho SC; Seah LL; Fong KS; Tai ES; Chee SP; Eng PH; Aw SE; Fok AC
    Thyroid; 1999 Dec; 9(12):1175-80. PubMed ID: 10646655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between thyroid stimulating hormone and thyroid stimulating immunoglobulin in Graves' hyperthyroidism.
    Woeber KA
    J Endocrinol Invest; 2011 Mar; 34(3):222-4. PubMed ID: 20855936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study.
    Diana T; Brown RS; Bossowski A; Segni M; Niedziela M; König J; Bossowska A; Ziora K; Hale A; Smith J; Pitz S; Kanitz M; Kahaly GJ
    J Clin Endocrinol Metab; 2014 May; 99(5):1648-55. PubMed ID: 24517152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Negative Thyretain TSI Bioassay Result does not Exclude the Possibility of the Presence of TSI.
    Kiaei D; Molinaro R
    Horm Metab Res; 2020 Feb; 52(2):124-125. PubMed ID: 32053844
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical diagnostic performance of a fully automated TSI immunoassay vs. that of an automated anti‑TSHR immunoassay for Graves' disease: a Chinese multicenter study.
    Cheng X; Chai X; Ma C; Jia Q; Zhao H; Dong Z; Zhang Z; Hu Y; Song A; Yang G; Qiu L; Lian X
    Endocrine; 2021 Jan; 71(1):139-148. PubMed ID: 32562184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of pediatric hyperthyroidism: technetium 99 uptake versus thyroid stimulating immunoglobulins.
    Baskaran C; Misra M; Levitsky LL
    Thyroid; 2015 Jan; 25(1):37-42. PubMed ID: 25257665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins.
    Lytton SD; Li Y; Olivo PD; Kohn LD; Kahaly GJ
    Clin Exp Immunol; 2010 Dec; 162(3):438-46. PubMed ID: 21070207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of clinical course with thyroid-stimulating immunoglobulin in Graves' ophthalmopathy in Mongolians.
    Bayarmunkh O; Ganbold C; Das S; Davaatseren U; Minjuurdorj NE; Jav S
    PLoS One; 2022; 17(11):e0277055. PubMed ID: 36395261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience.
    Ergin AB; Saralaya S; Olansky L
    Am J Otolaryngol; 2014; 35(6):784-90. PubMed ID: 25128909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
    Morris JC; Hay ID; Nelson RE; Jiang NS
    Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between thyroid stimulating immunoglobulins and thyrotropin binding inhibitory immunoglobulins levels in patients with Graves' disease].
    Jonas M; Ambroziak U; Nauman J
    Endokrynol Pol; 2006; 57(1):23-30. PubMed ID: 16575759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of thyroid-stimulating immunoglobulins in graves' ophthalmopathy.
    Ponto KA; Kanitz M; Olivo PD; Pitz S; Pfeiffer N; Kahaly GJ
    Ophthalmology; 2011 Nov; 118(11):2279-85. PubMed ID: 21684605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.